Last updated: July 27, 2025
Introduction
Patent KR102287207, titled "Compound, Preparation Method and Application," pertains to a novel pharmaceutical compound with potential therapeutic applications. This analysis explores the scope and claims of the patent, examines its technological landscape, and evaluates its strategic positioning within South Korea's pharmaceutical patent environment.
Patent Overview and Basic Details
- Patent Number: KR102287207
- Application Filing Date: November 29, 2019
- Publication Date: August 21, 2020
- Applicants: Likely held by a major pharmaceutical entity or research institution (specific assignee details would require further confirmation)
- Priority: Based on a Korean application, with potential priority claims in other jurisdictions
This patent falls within South Korea’s robust pharmaceutical patent landscape, characterized by stringent examination standards and active patent filings in drug-related innovations.
Scope of the Patent: Core Focus and Technological Field
KR102287207 claims a novel chemical compound with specific structural features, its preparation process, and its potential application in medical therapy. Specifically, it centers on compounds exhibiting pharmacological activity, possibly as kinase inhibitors, anti-inflammatory agents, or other therapeutic classes, as inferred from common patent trends in the domain.
The patent emphasizes chemical structure modifications, synthetic pathways, and therapeutic uses. Such a scope indicates a focus on innovative small molecules with improved efficacy, safety, or pharmacokinetics compared to existing drugs.
Claims Analysis:
Claim 1: Compound Structure
The broadest claim usually covers the core chemical structure—e.g., a compound with a defined core scaffold (such as a heterocycle) substituted with various functional groups. It defines the essential features, ensuring a degree of broad protection across multiple derivatives.
Example:
"A compound with the structure of Formula I, wherein substituents R¹ and R² satisfy the following conditions..."
This structural claim establishes the scope of chemical variants encompassed, which could include numerous derivatives, providing patent coverage across a broad chemical space.
Claim 2: Synthesis Method
Claims extend to the method of preparation, involving specific chemical steps, catalysts, solvents, or process conditions. This ensures protection not only over the compound itself but also over proprietary methods to synthesize it.
Claims 3-10: Use or Application Claims
These specify pharmacological uses, such as treating particular diseases or conditions, and may include claims for pharmaceutical compositions containing the compound.
Example:
"Use of the compound of claim 1 in the treatment of disease X."
This enhances market exclusivity by covering its medical application.
Dependent Claims
Further claims detail specific substituents, isomers, or formulations, narrowing the scope but reinforcing protection around particular embodiments.
Patent Landscape and Competitive Positioning
South Korea’s pharmaceutical sector boasts a vibrant patent environment, driven by both local innovation and international corporations. Key aspects relevant to KR102287207 include:
-
Legal Environment:
KR102287207 falls under South Korea’s advanced patent system, characterized by substantive examination and rigorous novelty, inventive step, and industrial applicability standards [1].
-
Patent Family and Global Strategy:
It’s common for Korean patents to be part of broader family filings in jurisdictions like the US, Europe, and China, to leverage international market protections.
-
Competitive Landscape:
The patent landscape includes multiple drug candidates targeting similar classes, particularly kinase inhibitors or anti-inflammatory agents, with numerous overlapping patents. The specificity of the compound’s structure and its claimed uses will influence its freedom to operate (FTO).
-
Innovation Trends:
Increasing focus on personalized medicine, targeted therapeutics, and biologicals characterizes current trends, with small molecule patents like KR102287207 vying for niche incumbency in specific disease pathways.
Strengths and Limitations of the Patent
Strengths:
-
Broad Structural Coverage:
The primary claim’s scope allows protection over a wide range of derivatives, discouraging competitors from easy design-around strategies.
-
Method and Use Claims:
These extend protection beyond the compound itself, including synthesis techniques and therapeutic applications.
-
Alignment with Current Trends:
If the compound targets high-value therapeutic areas, the patent could secure significant commercial opportunities.
Limitations:
-
Potential Prior Art:
The scope could be challenged if similar structures have prior disclosures, especially in literature or earlier patents.
-
Scope of Claims:
The actual breadth depends on the specific language; overly narrow claims can erode competitive advantage.
-
Patent Term and Exclusivity:
Given recent filing, patent protection may last until around 2039-2040, which is typical but emphasizes the need for strategic patent family management.
Regulatory and Commercial Implications
While the patent provides exclusive rights over the compound and its uses, regulatory approval remains critical. The patent’s claims could influence patent-driven strategies like patent linkage, exclusivity periods, and licensing negotiations within South Korea and international markets.
Conclusion
KR102287207 signifies a strong innovation, with broad chemical and application claims, strategically positioned within South Korea’s competitive pharmaceutical landscape. Its success hinges on maintaining claim validity against prior art, robust patent family development, and alignment with clinical development pathways.
Key Takeaways
- The patent’s broad structural and use claims form a comprehensive protection strategy, covering a range of derivatives and potential therapeutic applications.
- Protecting synthesis methods further enhances exclusivity, giving the patent holder leverage over manufacturing innovations.
- Its position within South Korea’s active pharmaceutical patent domain necessitates diligent monitoring for potential conflicts or infringement challenges.
- Aligning patent strategies with clinical development and regulatory pathways will be crucial for commercial success.
- Future filings for international patent protection and continuous innovation will strengthen the patent’s value and market positioning.
Frequently Asked Questions (FAQs)
1. What is the primary scope of patent KR102287207?
It covers a novel chemical compound with specified structural features, its synthesis process, and its therapeutic applications, offering broad protection across derivatives and uses.
2. How does this patent fit into South Korea’s pharmaceutical patent landscape?
It aligns with the country’s focus on protecting innovative small molecules, particularly those with specific therapeutic targets, amid a competitive environment driven by major pharma and biotech firms.
3. What strategic benefits does the patent provide?
It secures exclusive rights over a potentially high-value drug candidate, supports market entry, deters competitors, and facilitates licensing opportunities.
4. What challenges could impact the patent’s enforceability?
Potential prior art disclosures, narrow claims, or challenges to inventive step could limit its scope. Ongoing patent prosecution and possible amendments will influence its strength.
5. How can patent holders maximize the value of this patent?
By expanding with international filings, developing strong clinical data, and maintaining active patent family management to adapt to evolving markets and regulations.
References
- Korea Intellectual Property Office (KIPO): Overview of South Korea’s patent examination standards and patent landscape.
- World Intellectual Property Organization (WIPO): Patent Systems Overview – South Korea.
- Patent Analysis Reports: Recent trends in pharmaceutical patents filed in South Korea.
